Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912396415> ?p ?o ?g. }
- W2912396415 endingPage "1741" @default.
- W2912396415 startingPage "1731" @default.
- W2912396415 abstract "When transcatheter aortic valve replacement (TAVR) was first approved for use in the United States in 2012, multiple leading surgical and cardiology societies were tasked with creating recommendations and requirements for operators and institutions starting and maintaining TAVR programs. Creation of this consensus document was challenging due to limited experience with this new technology, and a lack of robust centralized data that could be used to validate outcome measures and create benchmarks for self-assessment and improvement. Despite these limitations, this document provided government agencies a framework for regulation that ultimately determined requirements for Medicare payment for TAVR and therefore greatly determined how and where care was delivered for patients with aortic stenosis. After the proliferation of TAVR institutions throughout the US and with data from more than 100,000 cases in the STS/ACC Transcatheter Valve Therapies TM Registry, leaders of the same societies reconvened in 2018 to update their consensus document. The new recommendations include suggested personnel, facilities, training, and assessment of outcomes and competencies required to run a safe and efficient TAVR program. This article seeks to detail the changes from the original consensus document with a particular focus on issues relevant to cardiac anesthesiologists as well as important healthcare policy ramifications for patients and providers in the United States. When transcatheter aortic valve replacement (TAVR) was first approved for use in the United States in 2012, multiple leading surgical and cardiology societies were tasked with creating recommendations and requirements for operators and institutions starting and maintaining TAVR programs. Creation of this consensus document was challenging due to limited experience with this new technology, and a lack of robust centralized data that could be used to validate outcome measures and create benchmarks for self-assessment and improvement. Despite these limitations, this document provided government agencies a framework for regulation that ultimately determined requirements for Medicare payment for TAVR and therefore greatly determined how and where care was delivered for patients with aortic stenosis. After the proliferation of TAVR institutions throughout the US and with data from more than 100,000 cases in the STS/ACC Transcatheter Valve Therapies TM Registry, leaders of the same societies reconvened in 2018 to update their consensus document. The new recommendations include suggested personnel, facilities, training, and assessment of outcomes and competencies required to run a safe and efficient TAVR program. This article seeks to detail the changes from the original consensus document with a particular focus on issues relevant to cardiac anesthesiologists as well as important healthcare policy ramifications for patients and providers in the United States." @default.
- W2912396415 created "2019-02-21" @default.
- W2912396415 creator A5018597226 @default.
- W2912396415 creator A5041080651 @default.
- W2912396415 creator A5059619717 @default.
- W2912396415 creator A5078228970 @default.
- W2912396415 creator A5079749832 @default.
- W2912396415 creator A5088088610 @default.
- W2912396415 date "2019-06-01" @default.
- W2912396415 modified "2023-10-17" @default.
- W2912396415 title "Operational and Institutional Recommendations and Requirements for TAVR: A Review of Expert Consensus and the Impact on Health Care Policy" @default.
- W2912396415 cites W161548076 @default.
- W2912396415 cites W1785342644 @default.
- W2912396415 cites W1880734873 @default.
- W2912396415 cites W1894479445 @default.
- W2912396415 cites W1938921375 @default.
- W2912396415 cites W2004714400 @default.
- W2912396415 cites W2051143811 @default.
- W2912396415 cites W2109553540 @default.
- W2912396415 cites W2121801221 @default.
- W2912396415 cites W2122545213 @default.
- W2912396415 cites W2135187257 @default.
- W2912396415 cites W2140394331 @default.
- W2912396415 cites W2143621465 @default.
- W2912396415 cites W2172198556 @default.
- W2912396415 cites W2175765132 @default.
- W2912396415 cites W2293244739 @default.
- W2912396415 cites W2318186500 @default.
- W2912396415 cites W2324073140 @default.
- W2912396415 cites W2337090803 @default.
- W2912396415 cites W2338828923 @default.
- W2912396415 cites W2465333108 @default.
- W2912396415 cites W2479385546 @default.
- W2912396415 cites W2491188335 @default.
- W2912396415 cites W2513593199 @default.
- W2912396415 cites W2534605893 @default.
- W2912396415 cites W2548157464 @default.
- W2912396415 cites W2559829689 @default.
- W2912396415 cites W2579717673 @default.
- W2912396415 cites W2584982307 @default.
- W2912396415 cites W2587881298 @default.
- W2912396415 cites W2596188051 @default.
- W2912396415 cites W2598204056 @default.
- W2912396415 cites W2718690139 @default.
- W2912396415 cites W2751096607 @default.
- W2912396415 cites W2775223817 @default.
- W2912396415 cites W2775394904 @default.
- W2912396415 cites W2890507005 @default.
- W2912396415 cites W2891519681 @default.
- W2912396415 cites W2898661543 @default.
- W2912396415 cites W4239414585 @default.
- W2912396415 cites W50775857 @default.
- W2912396415 cites W75725928 @default.
- W2912396415 doi "https://doi.org/10.1053/j.jvca.2019.01.062" @default.
- W2912396415 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30852090" @default.
- W2912396415 hasPublicationYear "2019" @default.
- W2912396415 type Work @default.
- W2912396415 sameAs 2912396415 @default.
- W2912396415 citedByCount "3" @default.
- W2912396415 countsByYear W29123964152021 @default.
- W2912396415 countsByYear W29123964152022 @default.
- W2912396415 countsByYear W29123964152023 @default.
- W2912396415 crossrefType "journal-article" @default.
- W2912396415 hasAuthorship W2912396415A5018597226 @default.
- W2912396415 hasAuthorship W2912396415A5041080651 @default.
- W2912396415 hasAuthorship W2912396415A5059619717 @default.
- W2912396415 hasAuthorship W2912396415A5078228970 @default.
- W2912396415 hasAuthorship W2912396415A5079749832 @default.
- W2912396415 hasAuthorship W2912396415A5088088610 @default.
- W2912396415 hasConcept C10138342 @default.
- W2912396415 hasConcept C126322002 @default.
- W2912396415 hasConcept C138885662 @default.
- W2912396415 hasConcept C144133560 @default.
- W2912396415 hasConcept C145097563 @default.
- W2912396415 hasConcept C160735492 @default.
- W2912396415 hasConcept C162324750 @default.
- W2912396415 hasConcept C164705383 @default.
- W2912396415 hasConcept C177713679 @default.
- W2912396415 hasConcept C2778137410 @default.
- W2912396415 hasConcept C2779703844 @default.
- W2912396415 hasConcept C2780007028 @default.
- W2912396415 hasConcept C2780026749 @default.
- W2912396415 hasConcept C3017605391 @default.
- W2912396415 hasConcept C41895202 @default.
- W2912396415 hasConcept C50522688 @default.
- W2912396415 hasConcept C545542383 @default.
- W2912396415 hasConcept C71924100 @default.
- W2912396415 hasConceptScore W2912396415C10138342 @default.
- W2912396415 hasConceptScore W2912396415C126322002 @default.
- W2912396415 hasConceptScore W2912396415C138885662 @default.
- W2912396415 hasConceptScore W2912396415C144133560 @default.
- W2912396415 hasConceptScore W2912396415C145097563 @default.
- W2912396415 hasConceptScore W2912396415C160735492 @default.
- W2912396415 hasConceptScore W2912396415C162324750 @default.
- W2912396415 hasConceptScore W2912396415C164705383 @default.
- W2912396415 hasConceptScore W2912396415C177713679 @default.
- W2912396415 hasConceptScore W2912396415C2778137410 @default.
- W2912396415 hasConceptScore W2912396415C2779703844 @default.